Edgewise Therapeutics, Inc. (EWTX) Social Stream



Edgewise Therapeutics, Inc. (EWTX): $18.24

0.28 (+1.56%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add EWTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#318 of 365

in industry

EDGEWISE THERAPEUTICS INC (EWTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering EWTX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-06 3 $34 $30 $31.666 $10.94 189.45%
2022-01-06 3 $34 $31 $32.666 $10.94 198.59%
2022-02-25 3 $34 $31 $32.333 $10.94 195.55%
2022-04-13 4 $34 $31 $32 $10.94 192.5%
2022-05-11 4 $32 $30 $31 $10.94 183.36%
2022-05-23 5 $31 $11 $26.2 $10.94 139.49%
2022-08-10 5 $31 $5 $25 $10.94 128.52%
2022-08-25 5 $31 $5 $25 $10.94 128.52%
2022-11-04 5 $31 $5 $24.8 $10.94 126.69%
2023-01-13 5 $32 $5 $24.2 $10.94 121.21%
2023-02-23 4 $32 $5 $24.2 $10.94 121.21%
2023-04-20 6 $32 $5 $23.6 $10.94 115.72%
2023-08-11 6 $32 $5 $23.666 $10.94 116.33%
2023-08-15 6 $32 $5 $23.833 $10.94 117.85%
2023-11-09 5 $32 $25 $27.6 $10.94 152.29%
2023-11-10 5 $32 $23 $26.8 $10.94 144.97%
2023-11-15 5 $32 $23 $26.4 $10.94 141.32%

The Trend in the Analyst Price Target


EWTX's average price target has moved down $0.6 over the prior 18 months.

EWTX reports an average of 213.95% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-11 6 32 5 23.833 9.515 150.48%
2023-06-11 6 32 5 23.666 9.630 145.75%
2023-08-11 6 32 5 23.666 6.710 252.7%
2023-09-17 5 32 25 27.600 6.420 329.91%
2023-11-15 5 32 23 26.400 6.560 302.44%

EWTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.2 4 1 0 0 0 5

The Trend in the Broker Recommendations


EWTX's average broker recommendation rating improved by 0.13 over the prior 19 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, EDGEWISE THERAPEUTICS INC's variance in analysts' estimates is lower than -1228.21% of them.
  • To contextualize these metrics, consider that out of all US stocks, EDGEWISE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2031.99% of them.
  • In the context of all US stocks, EDGEWISE THERAPEUTICS INC's number of analysts covering the stock is greater than 430.05% of them.
  • In terms of how EDGEWISE THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 1635.71% of that group.

Stocks similar to EDGEWISE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RAIN, VERA, and DAWN.

Make investment decisions regarding EWTX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!